Stocks

Participants Jeremiah Sisitsky; Vice President - Investor Relations; Zoominfo Technologies Inc Henry Schuck; Chairman of the Board, Chief Executive Officer; Zoominfo Technologies Inc Graham O'Brien; Interim Chief Financial Officer; Zoominfo Technologies Inc Alex Zukin; Analyst; Wolfe Research Mark Murphy; Analyst; JPMorgan Elizabeth Porter; Analyst; …

Freight delivery company Landstar (NASDAQ:LSTR) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.9% year on year to $1.15 billion. Its GAAP profit of $0.85 per share was 5.7% below analysts’ consensus estimates. Is now the time to buy Landstar? …

Online education Stride (NYSE:LRN) reported Q1 CY2025 results beating Wall Street’s revenue expectations , with sales up 17.8% year on year to $613.4 million. The company’s full-year revenue guidance of $2.38 billion at the midpoint came in 1.6% above analysts’ estimates. Its non-GAAP profit …

The market for Stryker Corporation's (NYSE:SYK) shares didn't move much after it posted weak earnings recently. Our analysis suggests that while the profits are soft, the foundations of the business are strong. This technology could replace computers: discover the 20 stocks are working to …

The United States market has shown positive momentum, climbing 3.9% in the last week and up 12% over the past year, with earnings expected to grow by 14% annually. For investors looking beyond established giants, penny stocks—often representing smaller or newer companies—can provide intriguing …

Under Armour (UAA) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to earnings of $0.11 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report …

Announced accepted oral presentation of positive phase 3 randomized placebo controlled clinical trial results of CAN-2409 (aglatimagene besadenovec) in localized prostate cancer at the 2025 American Society of Clinical Oncology (ASCO) Annual MeetingPreparations on track for Biologics License Application (BLA) for CAN-2409 in intermediate-to-high-risk …